PTC Therapeutics (PTCT) Shares Decline; German Reimbursement Arbitration Panel Said to Cut Price of Ataluren by 65%

February 26, 2016 3:37 PM

PTC Therapeutics (NASDAQ: PTCT) declined Friday after theStreet's Feuerstein said ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found